|
Volumn 47, Issue 6, 2007, Pages 981-986
|
Trigeminal autonomic cephalalgias: Current and future treatments - Commentary
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BACLOFEN;
CORTICOSTEROID;
ERGOTAMINE TARTRATE;
GABAPENTIN;
INDOMETACIN;
LAMOTRIGINE;
LIDOCAINE;
LITHIUM;
LITHIUM CARBONATE;
MELATONIN;
METHYLPREDNISOLONE;
METHYSERGIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OCTREOTIDE;
OXYGEN;
SUMATRIPTAN;
TOPIRAMATE;
VALPROIC ACID;
VERAPAMIL;
ZOLMITRIPTAN;
ANALGESIA;
BRAIN DEPTH STIMULATION;
CLUSTER HEADACHE;
CONSENSUS;
CONTINUOUS INFUSION;
DRUG DOSE REDUCTION;
EVIDENCE BASED MEDICINE;
FOLLOW UP;
GOOD CLINICAL PRACTICE;
HEMICRANIA CONTINUA;
HUMAN;
HYPOTHALAMUS;
INTRACTABLE PAIN;
MEDICAL SOCIETY;
NERVE STIMULATION;
NEUROSURGERY;
NOTE;
OCCIPITAL LOBE;
OUTCOME ASSESSMENT;
OXYGEN THERAPY;
PAROXYSMAL HEMICRANIA;
PILOT STUDY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RECOMMENDED DRUG DOSE;
SUNCT SYNDROME;
SYSTEMATIC REVIEW;
THERAPY RESISTANCE;
TRANSFORMED MIGRAINE;
TREATMENT INDICATION;
TREATMENT RESPONSE;
TRIGEMINAL AUTONOMIC CEPHALALGIA;
|
EID: 34250664318
PISSN: 00178748
EISSN: 15264610
Source Type: Journal
DOI: 10.1111/j.1526-4610.2007.00840.x Document Type: Note |
Times cited : (9)
|
References (3)
|